Global Pegfilgrastim Biosimilars Market Report (2022 to 2031) - Featuring Mylan, Biocon and Mundipharma Among Others
March 22, 2022 05:23 ET
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Report 2022: By Application, By Distribution" report has been added to ResearchAndMarkets.com's offering. This...
Global $4,037 Million Pegfilgrastim Biosimilars Markets, Analysis & Forecasts, 2015-2020, 2025F, 2030F
March 16, 2022 06:38 ET
|
Research and Markets
Dublin, March 16, 2022 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030, By Application, Distribution Channel" report has been added to...
Samsung Bioepis Celebrates 10 Years of Realizing Passion for Health, Innovating Patients Access Worldwide
February 28, 2022 04:40 ET
|
Samsung Bioepis
Holds a virtual ceremonial event for the first time to mark the anniversary with its global employees Pledges to keep innovating access to biologic medicines worldwide INCHEON, Korea, Feb. 28, 2022...
Worldwide Biosimilar Industry to 2027 - Featuring Novartis, Pfizer and Teva Among Others
February 22, 2022 08:28 ET
|
Research and Markets
Dublin, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
European Biosimilars Market Forecast to Grow by 23% Annually During 2020 to 2030
February 21, 2022 04:13 ET
|
Research and Markets
Dublin, Feb. 21, 2022 (GLOBE NEWSWIRE) -- The "Europe Biosimilars Market 2020-2030 by Product Type, Indication, Manufacturing, End User, and Country: Trend Forecast and Growth Opportunity" report...
$27.86Bn by 2028, Biopharmaceutical Contract Manufacturing Market Size, 8.5% CAGR Lead by Biologics - Exclusive Research Report by The Insight Partners
February 17, 2022 05:57 ET
|
The Insight Partners
New York, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Global...
Global Biologics CDMO Market Report 2022: A Market Valued at $9.9 Billion in 2020 - Competitive Developments, Strategies, Mergers and Acquisitions & New Product Developments to 2026
February 15, 2022 07:18 ET
|
Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Global Biologics CDMO Market (2022 Edition) - Analysis By Type (Mammalian, Non-Mammalian), Product Type (Biologics, Biosimilars), By Region, By...
Global Monoclonal Antibodies Market (2020 to 2030) - by Source, Category, Production Type, Application, End User and Region
January 25, 2022 05:43 ET
|
Research and Markets
Dublin, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies Market 2020-2030 by Source, Category, Production Type, Application, End User, and Region: Trend Forecast and Growth...
Biosimilars in Immunology Prescriber Opinions Survey 2021 - Factors Influencing Choice of Prescribed Biosimilar Brands
January 20, 2022 05:58 ET
|
Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Prescriber Opinions on Biosimilars in Immunology" report has been added to ResearchAndMarkets.com's offering. This report covers the 7MM (United...
Worldwide Biopharmaceutical Excipients Industry to 2026 - Substantial Rise in Need of Functional Excipients in Recent Years Presents Opportunities
January 07, 2022 07:18 ET
|
Research and Markets
Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Excipients Market Research Report by Product, by Function, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of...